Seelos Therapeutics, Inc. (SEEL) Social Stream
Seelos Therapeutics Inc (SEEL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SEEL.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
SEEL's average price target has moved down $2.75 over the prior 14 months.
Over the past 48 weeks, SEEL's average upside potential has been 323.6%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SEEL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 59 days, SEEL's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Seelos Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 488.99% of all US stocks.
- In the context of all US stocks, Seelos Therapeutics Inc's average analyst price target is higher than 29.41% of them.
- In terms of how Seelos Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -366.16% of that group.
- In the context of stocks in the small market cap category, Seelos Therapeutics Inc's number of analysts covering the stock is higher than 327.76% of them.
Make investment decisions regarding SEEL using the data that counts. Try POWR Ratings for free.